Molecular Studies on Cytochrome P-450 Lanosterol 14 Alpha-Demethylase Gene of Fluconazole Resistant Candida albicans Clinical Isolates (original) (raw)

The new mutation L321F in Candida albicans ERG11 gene may be associated with fluconazole resistance

Vagner Carvalho

Revista Iberoamericana de Micología, 2013

View PDFchevron_right

Formation of azole-resistant Candida albicans by mutation of sterol 14-demethylase P450

Osamu Gotoh

Antimicrobial agents and chemotherapy, 1999

View PDFchevron_right

Formation of Azole-Resistant Candida albicans by Mutation of Sterol 14-Demethylase P450

Osamu Gotoh

Antimicrobial Agents and Chemotherapy, 1999

View PDFchevron_right

Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans

Marcel Borgers, Hugo Vanden Bossche

Microbiology (Reading, England), 1999

View PDFchevron_right

Resistance mechanisms in fluconazole-resistant Candida albicans isolates from vaginal candidiasis

Julius Subik

International Journal of Antimicrobial Agents, 2006

View PDFchevron_right

Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India

Pallavi Vidhate

Mycoses, 2015

View PDFchevron_right

Phenotypic and molecular genetic profiles of fluconazole and voriconazole sensitive versus resistant candida spp

Priya Madhavan

2014

View PDFchevron_right

Prevalence of Molecular Mechanisms of Resistance to Azole Antifungal Agents in Candida albicans Strains Displaying High-Level Fluconazole Resistance Isolated from Human Immunodeficiency Virus-Infected Patients

Jose Cdr

Antimicrobial Agents and Chemotherapy, 2001

View PDFchevron_right

A New Variant of Mutational and Polymorphic Signatures in the ERG11 Gene of Fluconazole-Resistant Candida albicans

Anthony Mgbeahuruike

Infection and Drug Resistance

View PDFchevron_right

Amino Acid Substitutions in the Cytochrome P-450 Lanosterol 14a-Demethylase (CYP51A1) from Azole-Resistant Candida albicans Clinical Isolates Contribute to Resistance to Azole Antifungal Agents

Dominique Sanglard

1998

View PDFchevron_right

Establishing Surrogate Markers for Fluconazole Resistance in Candida albicans

David Perlin

Microbial Drug Resistance, 2005

View PDFchevron_right

In Vitro Fluconazole Susceptibility of 1,903 Clinical Isolates of Candida albicans and the Identification of ERG11 Mutations

Ying Ying

Microbial Drug Resistance, 2013

View PDFchevron_right

Amino Acid Substitutions in the Cytochrome P-450 Lanosterol 14α-Demethylase (CYP51A1) from Azole-Resistant Candida albicans Clinical Isolates Contribute to Resistance to Azole Antifungal Agents

Dominique Sanglard

Antimicrobial Agents and Chemotherapy, 1998

View PDFchevron_right

Detection of ERG11 point mutations in iranian fluconazole-resistant Candida albicans isolates

Hossein Zarrinfar

Current Medical Mycology, 2019

View PDFchevron_right

Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature

Florent Morio

Diagnostic microbiology and infectious disease, 2010

View PDFchevron_right

Evolution of Fluconazole Resistance in Candida albicans

Martin Engman

… Unit Technical Report …, 2000

View PDFchevron_right

The amino acid substitution N136Y in Candida albicans sterol 14alpha-demethylase is involved in fluconazole resistance

Audrey FLEURY

Medical mycology, 2016

View PDFchevron_right

Clonal and spontaneous origins of fluconazole resistance in Candida albicans

Thomas Mitchell

Journal of clinical microbiology, 2000

View PDFchevron_right

Using PCR to Compare the Expression of CDR1, CDR2, and MDR1 in Candida Albicans Isolates Resistant and Susceptible to Fluconazole

Ali Nazemi

Medical Laboratory Journal, 2015

View PDFchevron_right

Rapid detection of ERG11 gene mutations in clinical Candida albicans isolates with reduced susceptibility to fluconazole by rolling circle amplification and DNA sequencing

Fanrong Kong

BMC Microbiology, 2009

View PDFchevron_right

Combination of different molecular mechanisms leading to fluconazole resistance in a Candida lusitaniae clinical isolate

Bruno Silva

Diagnostic Microbiology and Infectious Disease, 2009

View PDFchevron_right

Changes in susceptibility to posaconazole in clinical isolates of Candida albicans

Guillermo Quindós

Journal of Antimicrobial Chemotherapy, 2003

View PDFchevron_right

Investigation of Fluconazole Susceptibility to Candida Albicans by MALDI-TOF MS and Real-Time PCR for CDR1, CDR2, MDR1 and ERG11

Worada Samosornsuk

2021

View PDFchevron_right

Genetic Dissection of Azole Resistance Mechanisms in Candida albicans and Their Validation in a Mouse Model of Disseminated Infection

Alix Coste

Antimicrobial Agents and Chemotherapy, 2010

View PDFchevron_right

Hugo Vanden Bossche

1997

View PDFchevron_right

Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance

Riccardo Torelli

Antimicrobial agents and chemotherapy, 2005

View PDFchevron_right

Experimental Induction of Fluconazole Resistance in Candida tropicalis ATCC 750

David Calabrese

Antimicrobial Agents and Chemotherapy, 2000

View PDFchevron_right

Molecular Studies on Cytochrome P-450 Lanosterol 14 Alpha-Demethylase Gene of Fluconazole Resistant Candida albicans Clinical Isolates (original) (raw)

Related papers